Harm reduction measures and anti-retroviral therapy are cutting down B.C.’s HIV infection rates among injection drug users, says a new report released Thursday by the Health Ministry.
Provincial health officer Dr. Perry Kendall released a report revealing several factors associated with the drop in intravenous drug users catching HIV or hepatitis C.
Among the factors mentioned is a therapy Kendall describes as the “current gold standard in HIV treatment” – the highly active anti-retroviral therapy (HAART).